“…Another explanation is that the mechanisms of action of statins and aspirin in glaucoma progression, which are not yet fully elucidated, may exert a differential effect on the optic nerve. It is likely that aspirin may not prevent glaucoma development as we had hypothesized; its action as a cyclo‐oxygenase inhibitor decreases prostaglandin production, which may theoretically increase IOP 35,36 . Though all of our subjects remained normotensive by design, there may nevertheless be a subtle competing effect between aspirin and statins on glaucoma progression.…”